Literature DB >> 15390094

Glial-mediated neuroprotection: evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system.

Thimmasettappa Thippeswamy1, Jennifer S McKay, Richard Morris, John Quinn, Liang-Fong Wong, David Murphy.   

Abstract

The NO-cGMP pathway has emerged as a neuroprotective signaling system involved in communication between neurons and glia. We have previously shown that axotomy or nerve growth factor (NGF)-deprivation of dorsal root ganglion (DRG) neurons leads to increased production of NO and at the same time an increase in cGMP production in their satellite glia cells. Blockade of NO or its receptor, the cGMP synthesizing enzyme soluble guanylate cyclase (sGC), results in apoptosis of neurons and glia. We now show that co-culture of neonatal DRG neurons with either Schwann cells pre-treated with an NO donor or a membrane-permeant cGMP analogue; or neurons maintained in the medium from Schwann cell cultures treated in the same way, prevents neuronal apoptosis. Both NO donor and cGMP treatment of Schwann cells results in synthesis of NGF and NT3. Furthermore, if the Schwann cells are previously infected with adenoviral vectors expressing a dominant negative sGC mutant transgene, treatment of these Schwann cells with an NO donor now fails to prevent neuronal apoptosis. Schwann cells treated in this way also fail to express neither cGMP nor neurotrophins. These findings suggest NO-sGC-cGMP-mediated NGF and NT3 synthesis by Schwann cells protect neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15390094     DOI: 10.1002/glia.20105

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

1.  Satellite cells of sensory neurons after various types of sciatic nerve trauma in the rat.

Authors:  S S Arkhipova; I S Raginov; A R Mukhitov; Y A Chelyshev
Journal:  Neurosci Behav Physiol       Date:  2010-06-09

Review 2.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury.

Authors:  Joyce A Benjamins; Liljana Nedelkoska
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

4.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

5.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

Review 6.  Neurorestorative treatment of stroke: cell and pharmacological approaches.

Authors:  Jieli Chen; Michael Chopp
Journal:  NeuroRx       Date:  2006-10

7.  Protein Kinase G facilitates EGFR-mediated cell death in MDA-MB-468 cells.

Authors:  Nicole M Jackson; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2016-07-02       Impact factor: 3.905

8.  Nitric oxide-NGF mediated PPTA/SP, ADNP, and VIP expression in the peripheral nervous system.

Authors:  Thimmasettappa Thippeswamy; Mark R Howard; Anna Siobhan Cosgrave; Daleep Kumar Arora; Jennifer S McKay; John P Quinn
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

9.  Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.

Authors:  Alessandro Capuano; Alice De Corato; Lucia Lisi; Giuseppe Tringali; Pierluigi Navarra; Cinzia Dello Russo
Journal:  Mol Pain       Date:  2009-08-06       Impact factor: 3.395

10.  Nerve growth factor regulates synaptophysin expression in developing trigeminal ganglion neurons in vitro.

Authors:  L Tarsa; A Balkowiec
Journal:  Neuropeptides       Date:  2008-11-18       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.